|
HY-100237-10mg
|
MedChemexpress LLC
|
SZL P1-41 [CAS 222716-34-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100237-100mg
|
MedChemexpress LLC
|
SZL P1-41 [CAS 222716-34-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100237-25mg
|
MedChemexpress LLC
|
SZL P1-41 [CAS 222716-34-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100237-5mg
|
MedChemexpress LLC
|
SZL P1-41 [CAS 222716-34-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100237-50mg
|
MedChemexpress LLC
|
SZL P1-41 [CAS 222716-34-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100385-10mg
|
MedChemexpress LLC
|
Brevianamide F [CAS 38136-70-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100385-100mg
|
MedChemexpress LLC
|
Brevianamide F [CAS 38136-70-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100385-25mg
|
MedChemexpress LLC
|
Brevianamide F [CAS 38136-70-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100385-5mg
|
MedChemexpress LLC
|
Brevianamide F [CAS 38136-70-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100385-50mg
|
MedChemexpress LLC
|
Brevianamide F [CAS 38136-70-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100555-1mg
|
MedChemexpress LLC
|
CH5138303 [CAS 959763-06-5]
|
|
COVID-19-anti-virus
|
|
|
HY-101427-10mg
|
MedChemexpress LLC
|
Bamaquimast [CAS 135779-82-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101427-100mg
|
MedChemexpress LLC
|
Bamaquimast [CAS 135779-82-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101427-5mg
|
MedChemexpress LLC
|
Bamaquimast [CAS 135779-82-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101427-50mg
|
MedChemexpress LLC
|
Bamaquimast [CAS 135779-82-7]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-109142-10mg
|
MedChemexpress LLC
|
Ziresovir [CAS 1422500-60-4]
|
|
COVID-19-anti-virus
|
|
|
HY-109142-100mg
|
MedChemexpress LLC
|
Ziresovir [CAS 1422500-60-4]
|
|
COVID-19-anti-virus
|
|
|
HY-109142-25mg
|
MedChemexpress LLC
|
Ziresovir [CAS 1422500-60-4]
|
|
COVID-19-anti-virus
|
|
|
HY-109142-5mg
|
MedChemexpress LLC
|
Ziresovir [CAS 1422500-60-4]
|
|
COVID-19-anti-virus
|
|
|
HY-109142-50mg
|
MedChemexpress LLC
|
Ziresovir [CAS 1422500-60-4]
|
|
COVID-19-anti-virus
|
|
|
HY-10949-10mg
|
MedChemexpress LLC
|
SMER3 [CAS 67200-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-10949-100mg
|
MedChemexpress LLC
|
SMER3 [CAS 67200-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-10949-25mg
|
MedChemexpress LLC
|
SMER3 [CAS 67200-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-10949-5mg
|
MedChemexpress LLC
|
SMER3 [CAS 67200-34-4]
|
|
Cancer-programmed cell death
|
|
|
HY-10949-50mg
|
MedChemexpress LLC
|
SMER3 [CAS 67200-34-4]
|
|
Cancer-programmed cell death
|
|
